The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
Stem cell research based on somatic cell cloning embryos will be resumed in South Korea in seven years after a bioethical controversy rocked the country.
The Ministry of Health and Welfare Monday gave conditional approval to the CHA University’s plan to research somatic cell cloning embryos, a move that is expected to help accelerate the country’s research on embryonic stem cell cloning that has been halted in the wake of one of the worst data fabrication scandals in the science community[.]
The CHA university plans to use stem cell lines derived from somatic cell cloning embryos in cell therapy for patients with optic nerve damage, stroke and osteochondral defect and the research will last until December 31, 2020.
The latest approval was given as the university met the requirements from the National Bioethics Committee [on May 2016] that the egg should be taken legitimately, an independent ethical committee should be in place and a monitoring system to block human cloning is established.
Read full, original post: Stem cell research to be resumed in South Korea in 7 yrs after halt